FIELD: chemical industry. SUBSTANCE: described are new benzazepin-, benzoxazepin, benzothiazepin N-acetic acid derivatives of general formula I: wherein R1 is (lower) alkoxy (lower) alkyl group, lower alkoxy residue of which group is substituted by lower alkoxy group, phenyl (lower) alkyl group; or phenyloxy (lower) alkyl group which is optionally substituted by lower alkyl, lower alkoxy or halogen in phenyl ring, or naphthyl (lower) alkyl group; A is CH2, O or S; R2 is hydrogen or halogen; R3 is hydrogen or halogen; R4 is hydrogen or biolabile ester-forming group; R5 is hydrogen or biolabile ester - forming group and physiologically tolerable salts of acids of formula I. Said compounds have useful pharmacological properties which are effective with respect to heart and show clearly expressed suppressing effect on neutral endopeptidase, diminish high heart filling pressure that occurs because of heart insufficiency and thus discharge heart and may induce greater liuresis. Also described are method of preparing compounds of formula I and drug that contains said compounds. EFFECT: improved properties of the title compounds. 9 cl, 21 ex, 1 tbl
Title |
Year |
Author |
Number |
DERIVATIVES OF BENZAZEPINON-N-ACETIC ACID SUBSTITUTED WITH PHOSPHONIC ACID, METHOD FOR THEIR PREPARING AND MEDICINAL AGENTS CONTAINING THESE COMPOUNDS |
1998 |
- Val'Dek Kharal'D
- Majl' Jorg
- Tormelen Dirk
- Vurl' Mikhel'
|
RU2211219C2 |
MEDICINAL AGENT FOR HYPERTENSION TREATMENT |
2000 |
- Uilkinz Martin R.
- Tormehlen Dirk
- Val'Dek Kharal'D
|
RU2270679C2 |
MEDICINAL AGENT POSSESSING PROTECTIVE EFFECT WITH RESPECT TO OXIDATIVE-TOXIC AND CARDIOTOXIC COMPOUNDS MAINLY |
2000 |
- Rozha Zhuzhanna
- Papp Julius D.
- Tormehlen Dirk
|
RU2268727C2 |
SOLID BENZAZEPIN COMPOUND SALTS AND THEIR USE IN PREPARATION OF PHARMACEUTICAL COMPOUNDS |
2003 |
- Van Der Ehrden Joris A.
- De Jong Paulus P. G.
- Van Der Mej Paulus F. K.
|
RU2303041C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING NEP-INHIBITORS, INHIBITORS OF ENDOGENOUS ENDOTHELIN-PRODUCING SYSTEM AND AT-RECEPTOR ANTAGONISTS |
2005 |
- Tsigler Diter
- Vitte Klaus
- Shtraub Mattias
- Fisher Ivan
- Tormehlen Dirk
- Khel'T'E Dagmar
|
RU2384346C2 |
DERIVATIVES OF [2R,3R(2′R,3′R),6R,7S,8S,9R,10R]-3-(2′,3′-DIHYDROXYPENT-2′-YL)- -2,6,8,10,12-PENTAMETHYL-4,13-DIOXOBICYCLO [8,2,1]-TRIDEC-12-ENE-5-ON, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL AGENT |
1992 |
- Dagmar Khel'T'E[De]
- Ulf Projshoff[De]
- Kristian Ehkkhout[Nl]
|
RU2107070C1 |
PHARMACEUTICAL COMPOSITIONS, INCLUDING NEP INHIBITORS, INHIBITORS OF SYSTEM PRODUCING ENDOGENIC ENDOTHELIUM AND DIURETICS |
2006 |
- Vitte Klaus
- Tsigler Diter
- Shtraub Mattias
- Fisher Ivan
|
RU2409366C2 |
INHIBITORS OF NEUTRAL ENDOPEPTIDASE (NEP) HUMAN SOLUBLE ENDOPEPTIDASE (hSEP) FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS |
2005 |
- Veske Mikhel'
- Turski Lekhoslav A.
- Ikonomidou Khrissanti
- Tsigler Diter
|
RU2362563C2 |
1,7-ANULAR DERIVATIVES OF 3-(PIPERAZINOALKYL)-INDOLE, METHOD OF THEIR SYNTHESIS (VARIANTS), PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND AN INTERMEDIATE COMPOUND FOR THEIR SYNTHESIS |
1992 |
- Daniehl' Zhasseran[Us]
- Dominik Pari[Us]
- Patris Demonsho[Us]
- Mishel' Kottin[Us]
- Fransua Flosh[Us]
- P'Er Djupass'E[Fr]
- Richard Vajt[Us]
|
RU2083580C1 |
ORAL COMPOSITION COMPRISING DIFFICULTLY WATER-SOLUBLE ACTIVE SUBSTANCE SOLID SOLUTION |
2003 |
|
RU2314811C2 |